Efficacy of Amplification With Hearing Aids for Tinnitus Relief
Key facts
- Who runs it
- Education University of Hong Kong
- Where
- Hong Kong1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 64 people enrolled
- Started
- 1 Nov 2018
- Ended
- 31 Dec 2023
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Amplification with hearing aid
- Customized music
- Record updated
- 4 March 2024
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
Show the full registry criteria (14)Hide the full registry criteria
Who can take part
- 18 years old or above
- can provide written informed consent
- have a diagnosis of subjective tinnitus, i.e., the tinnitus can only be heard by the patient and there is no acoustic source
- a tinnitus duration of more than one year
- have pure-tone average between 20 and 40 dB HL
- have bilateral symmetrical hearing loss (i.e. difference less than 15 dB)
- have at least a medium level of distress caused by tinnitus as indicated with total scores above 30 on the TQ-CH
- are committed to complete the 12-month follow-up
Who cannot take part
- received other forms of tinnitus treatments within three months before the baseline assessment session
- any history suggestive of psychiatric illness
- objective tinnitus, i.e. tinnitus produced by an internal acoustic source activating the cochlea and can be heard by another person
- psychological distress or depression as indicated with total scores at or above 15 on the Cantonese HADS
- current hearing aid users
- inability to complete the study as revealed by the medical reports
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study evaluates the treatment efficacy of tinnitus in people with mild hearing loss. One-third of participants will use hearing aid, one-third of participants will use customized music, while the other one-third participants will receive no treatment (waiting list control).
The 3 groups in the trial
- Waiting list control groupNo study treatment, for comparison
There will be no treatment for 12 months.
- Hearing aid groupTreatment being tested
Participants will receive amplification with hearing aids. Bilateral open-fit hearing aids will be fitted. Participants will be required to use the hearing aids for at least 2 hours daily for 12 months.
Treatment: Amplification with hearing aid
- Customized music groupExisting treatment, for comparison
Customized music according to participants hearing level will be made available in an iPod. The iPod will deliver ear-specific therapeutic sound for asymmetrical hearing profile. Participants will have to listen to the therapeutic sound at a comfortable volume for two hours daily for 12 months.
Treatment: Customized music
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Efficacy of Amplification With Hearing Aids for Tinnitus Relief: a Randomized Controlled Trial
- Publications
- Efficacy of Amplification for Tinnitus Relief in People With Mild Hearing Loss.Journal of speech, language, and hearing research : JSLHR, 2024
- Record updated
- 4 March 2024